
An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.
An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.
Charitable Pharmacies of America organization member receives Health Equity grant
Significant improvement in glycemic control among participants demonstrates the substantial impact that pharmacies partnered with charitable medication distributors such as the Dispensary of Hope can have on individuals with insulin-treated T2D
We estimate that if the PHE expires in April 2023, 18.0 million people will lose Medicaid coverage in the following…
In 2011, the opioid crisis reached astounding levels with over 21,000 deaths adding to the urgency of providing aid to those who most need it
An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.
Today’s release of new 2020 Census data provides population counts of nearly 1,500 race and ethnicity groups and American Indian and Alaska Native (AIAN) tribes and villages.
APPLICATIONS ARE OPEN! – Letters of Intent due 9/15/23
Around one fourth of the United States population does not have adequate health literacy.
Health literacy is defined as the ability to obtain, read, understand, and apply healthcare
information
Good Pill will provide direct access to hundreds of life-saving medications and save families $150+/month on healthcare cost
How a ‘weighted lottery’ helped underserved patients get a scarce Covid drug
St. Vincent de Paul Charitable Pharmacy offers article regarding impact of a charitable pharmacy on their community and patients
Starting Sept. 25, Americans can again order free COVID-19 tests through the federal government.
A Fireside Chat with AAM Chair, Christine Baeder and Mark Cuban, Entrepreneur and Cost Plus founder
There are multiple factors that will impact an individual patient’s choice on how to go about getting their prescription medication. It can be overwhelming to navigate this complex issue.
NABP Associate Executive Director Josh Bolin on DSCSA compliance prior to FDA moving compliance deadline.